A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

Intellia Therapeutics reported further progress with two treatments that are now ensconced in Phase III of testing. Click ...

BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest ...

A dozen Canadian groups are leading exhibition at this year's Venice Biennale, which opened this month. Here's what they have ...

Dr Ian Archer joins the James Hutton Institute as commercial director, bringing deep expertise in biotechnology and industrial chemistry.

The bonds built over eight years of planning and construction were on full display last week when hundreds gathered to ...

Opening a new chapter in the University of California, Davis’ role as a regional engine of innovation and economic growth, ...

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...

Colossal Biosciences, a Texas-based biotech company, made headlines this April after falsely claiming to resurrect the ...

This comes as more students are choosing the polytechnic route despite qualifying for junior college. Read more at ...

Our Blood Institute, the primary provider for more than 5 million residents across Oklahoma, Texas and Arkansas, has appointed Dr. Jesse McCool as COO.